Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis
Biological products for treatment of rheumatoid arthritis usually are cost effective for healthcare systems in Europe, but they are huge financial burden due to the high number of patients and the significant budget impact. The expected saving from introduction on the market of biosimilars are signi...
Saved in:
Main Authors: | Manoela Manova (Author), Alexandra Savova (Author), Maria Vasileva (Author), Silvia Terezova (Author), Maria Kamusheva (Author), Daniela Grekova (Author), Valentina Petkova (Author), Guenka Petrova (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of Cardiovascular Medicines Prices in Four European Countries
by: Zornitsa Mitkova, et al.
Published: (2020) -
An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries
by: Maria Kamusheva, et al.
Published: (2018) -
Аn affordability of statins therapy - comparative analysis between Ukraine and Bulgaria
by: Oksana Tkachova, et al.
Published: (2019) -
Incretins and SGLT-2i Therapy of Type 2 Diabetes - Real Life Study of Their Therapeutic and Economic Effects
by: Zornitsa Mitkova, et al.
Published: (2019) -
Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries
by: Maria Kamusheva, et al.
Published: (2018)